Business Wire

BLUE-PLANET-SCIFI

5.1.2022 14:38:10 CET | Business Wire | Press release

Share
“Honorary Space Station” of the Third Blue Planet Science Fiction Film Festival Docks Successfully in Niushou Mountain, Nanjing, China

The “Honorary Space Station” event of the Third Blue Planet Science Fiction Film Festival, China’s first and only film festival dedicated to the sci-fi genre, was held on December 28, 2021 in the scenic Niushou Mountain area of Nanjing.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220105005648/en/

Since its debut in November 2019, more than 40% of the projects supported by the festival’s venture initiative have secured contracts with top-tier companies in China. Niushou Mountain Cultural Tourism Zone, which plays host to the Blue Planet Festival, has emerged as a base of sci-fi cluster in Nanjing, helping to attract sci-fi film talents, new projects, technologies, and investment from around the world.

This year’s event, themed “Migrating”, features four sections: From the New World, The Mission of Science and Technology, The Honor of Film, and The Migration of Civilization, covering various aspects of the sci-fi world, from space travel and film technology to industry and civilization.

The festival opened with the pilot film “Let There Be Light,” which looked back at the trials and tribulations that the sci-fi film industry and wider society have been through since the start of the pandemic. From a total of 254 works submitted from around the world, the top 12 works selected at this year’s festival reflected the diversity of the sci-fi film world, tackling themes from time travel to human civilization and extra-terrestrial species. Top awards went to Green Food (Best Sci-Fi Film), Yitong Ling (Best Sci-Fi Director for Triffin Dilemma), Double Helix (Best Sci-Fi Performance), Orogenèse (Best Visual Imagination), and Out of Darkness (Best Sci-Fi Animation & Script). Out of Darkness also won the Blue Planet STAR award, which was awarded based on audience emotional reception as gauged with special biosensing technology.

This year’s program also featured a special section of six sci-fi films from Russia, a country with a long and storied history of sci-fi works, ranging from Soviet-era classics to contemporary releases. In addition, a special planning and observation program, focused on sci-fi film and animation works released or broadcast since November 2020, was created, where experts provided analysis and insights to highlight the progress of China’s sci-fi sector, obstacles to further development, and possible solutions to promote the all-around growth of the industry.

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AHS Properties to Launch USD 1.3 Billion AHS Twin Towers, a Grade A Commercial Office Building on Sheikh Zayed Road27.10.2026 13:17:00 CET | Press release

AHS Properties is set to launch AHS Twin Towers, its new commercial development on Sheikh Zayed Road, following the AED 1.1 billion acquisition of Shangri-La Dubai. The property will undergo a major transformation into a Grade A commercial destination. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027110920/en/ Abbas Sajwani, Founder and CEO of AHS Properties (Photo: AETOSWire) Positioned on one of Dubai’s most prominent commercial corridors, AHS Twin Towers will introduce a new architectural identity for the property. The project has been designed by Gensler, an internationally recognised architecture and design firm, with interiors by AHS Atelier, the company’s in-house design studio, bringing a bespoke approach to materiality, detailing and craftsmanship throughout the development. AHS Twin Towers will comprise ground floor plus 50. The development will offer flexible Grade A office environments supported by an integr

JERA Signs a Binding Heads of Agreement with AM Green for Long-Term Supply of Green Ammonia for Maritime Decarbonization27.10.2026 13:11:00 CET | Press release

JERA Co., Inc. (JERA) and AM Green Ammonia (India) Private Limited (AM Green) today jointly announced that it has entered into a Binding Heads of Agreement ("HoA") with AM Green regarding the long-term supply of green ammonia produced in India. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027189014/en/ JERA and AM Green have agreed upon supply of approximately 70,000 tonnes of green ammonia annually over five years, with potential extension of term for additional supply. The green ammonia is intended to be supplied through receiving, storage and distribution facilities being developed adjacent to JERA's Hekinan Thermal Power Station in Aichi Prefecture, Japan. Green ammonia would primarily be supplied to a business venture jointly to be established by Kawasaki Kisen Kaisha, Ltd. and Nippon Yusen Kabushiki Kaisha, which plans to utilize an ammonia bunkering vessel to supply fuel to ammonia-fueled car carriers. This marks

Pythia Labs Launches with AI-Designed Antibodies for Hard-to-Drug Targets27.10.2026 13:00:00 CET | Press release

Biotech startup demonstrates rapid AI design of full-length human antibodies that inhibit or activate GPCRs, with key properties required for therapeutic development Pythia Labs, a biotechnology company building frontier AI models for therapeutic discovery, today announced its launch alongside a preprint in bioRxiv introducing Pythia-1, the all-atom generative model at the core of its antibody design platform. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027891477/en/ Pythia's AI technology platform can design antibodies against traditionally challenging targets such as multi-pass membrane proteins. Pythia’s technology is built to create antibodies against targets that have challenged conventional discovery, including multi-pass membrane proteins such as G protein-coupled receptors (GPCRs). Generating antibodies that activate these receptors has been a longstanding goal in antibody discovery. Pythia-1 reasons jointly ov

Robbyant’s Inaugural Embodied AI Challenge Draws Over 1,800 Teams Ahead of Real-Robot Final in Shanghai27.10.2026 12:00:00 CET | Press release

Qualifier submissions for the inaugural Robbyant Embodied AI Challenge officially closed on October 27, marking the end of the competition’s online preliminary round. Organized by Robbyant, an embodied AI company within Ant Group, the challenge was launched in September at the 2026 Inclusion Conference on the Bund in partnership with ModelScope and Alibaba Cloud Tianchi. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261027768483/en/ The competition is based on the open-source LingBot-VLA 2.0 embodied foundation model and is designed for developers working on embodied AI algorithms. Participants are evaluated on model training and fine-tuning, simulation-based generalization, and adaptation to real robots. The challenge is open to enterprises, universities, individual developers and technology enthusiasts worldwide. More than 1,800 teams and thousands of developers from 13 countries have registered for the challenge. Partici

Compass Pathways to Announce Third Quarter 2026 Financial Results on November 3, 202627.10.2026 11:30:00 CET | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that it will release financial results for the third quarter ended September 30, 2026, and provide an update on recent developments, on November 3, 2026. Compass management will host a conference call at 8:00 am ET (1:00 pm UK) on November 3, 2026. A live webcast of the call will be available at the following link: https://lifescievents.com/event/csy40je/. The webcast will be archived for 30 days. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under evaluation for treatment-resistant depression (TRD) and post-traumati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye